Japan Tissue Engineering Co., Ltd. (7774.T)
JPY 630.0
(-0.16%)
JPY 630.0
(-0.16%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 244.81 Million JPY | 146.69% |
| 2022 | -597 Million JPY | -60.48% |
| 2021 | -374 Million JPY | -9.8% |
| 2020 | -359.89 Million JPY | -205.26% |
| 2019 | -112 Million JPY | 51.78% |
| 2018 | -231 Million JPY | -170.2% |
| 2017 | 335.51 Million JPY | -22.95% |
| 2016 | 432.12 Million JPY | 172.52% |
| 2015 | -587 Million JPY | 0.42% |
| 2014 | -585.58 Million JPY | 18.69% |
| 2013 | -721.77 Million JPY | 25.38% |
| 2012 | -968.22 Million JPY | -25.38% |
| 2011 | -971.79 Million JPY | 3.65% |
| 2010 | -1.01 Billion JPY | -1.34% |
| 2009 | -946.08 Million JPY | 3.3% |
| 2008 | -989 Million JPY | -14.5% |
| 2007 | -944 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -154.2 Million JPY | -166.8% |
| 2024 Q2 | 26.5 Million JPY | 117.23% |
| 2023 Q1 | 14.21 Million JPY | 113.71% |
| 2023 Q2 | -25.06 Million JPY | -276.37% |
| 2023 FY | - JPY | 146.69% |
| 2023 Q3 | -40.81 Million JPY | -62.84% |
| 2023 Q4 | 264.37 Million JPY | 747.7% |
| 2022 FY | - JPY | -60.48% |
| 2022 Q1 | -267.09 Million JPY | -68.5% |
| 2022 Q2 | -152.91 Million JPY | 42.75% |
| 2022 Q3 | -204.45 Million JPY | -33.7% |
| 2022 Q4 | -103.65 Million JPY | 49.3% |
| 2021 Q2 | -138.19 Million JPY | -6.5% |
| 2021 FY | - JPY | -9.8% |
| 2021 Q1 | -129.76 Million JPY | -128.43% |
| 2021 Q3 | -71.68 Million JPY | 48.13% |
| 2021 Q4 | -158.51 Million JPY | -121.13% |
| 2020 Q3 | -137.77 Million JPY | -41.18% |
| 2020 Q2 | -97.58 Million JPY | 44.14% |
| 2020 Q1 | -174.69 Million JPY | -235.69% |
| 2020 FY | - JPY | -205.26% |
| 2020 Q4 | -56.8 Million JPY | 58.77% |
| 2019 FY | - JPY | 51.78% |
| 2019 Q3 | -92.03 Million JPY | -5.79% |
| 2019 Q2 | -86.99 Million JPY | 52.92% |
| 2019 Q1 | -184.79 Million JPY | -240.87% |
| 2019 Q4 | 128.74 Million JPY | 239.89% |
| 2018 Q3 | -57.81 Million JPY | -412.27% |
| 2018 FY | - JPY | -170.2% |
| 2018 Q1 | -441.61 Million JPY | -590.87% |
| 2018 Q2 | 18.51 Million JPY | 104.19% |
| 2018 Q4 | 131.17 Million JPY | 326.9% |
| 2017 Q3 | 36.64 Million JPY | -53.53% |
| 2017 Q2 | 78.86 Million JPY | 1207.26% |
| 2017 FY | - JPY | -22.95% |
| 2017 Q1 | 6.03 Million JPY | -98.82% |
| 2017 Q4 | 89.96 Million JPY | 145.49% |
| 2016 FY | - JPY | 172.52% |
| 2016 Q4 | 511.32 Million JPY | 1478.77% |
| 2016 Q3 | -37.08 Million JPY | 8.28% |
| 2016 Q2 | -40.43 Million JPY | 66.7% |
| 2016 Q1 | -121.41 Million JPY | -2669.02% |
| 2015 Q2 | -202.91 Million JPY | 13.61% |
| 2015 Q3 | -289.52 Million JPY | -42.68% |
| 2015 Q4 | 4.72 Million JPY | 101.63% |
| 2015 FY | - JPY | 0.42% |
| 2015 Q1 | -234.87 Million JPY | -426.8% |
| 2014 Q2 | -313.34 Million JPY | -49.02% |
| 2014 Q4 | 71.87 Million JPY | 132.12% |
| 2014 FY | - JPY | 18.69% |
| 2014 Q1 | -210.26 Million JPY | -193.2% |
| 2014 Q3 | -223.73 Million JPY | 28.6% |
| 2013 Q3 | -251.62 Million JPY | 6.01% |
| 2013 Q1 | -221.75 Million JPY | 7.86% |
| 2013 FY | - JPY | 25.38% |
| 2013 Q4 | -71.71 Million JPY | 71.5% |
| 2013 Q2 | -267.71 Million JPY | -20.73% |
| 2012 Q1 | -301.85 Million JPY | -24.95% |
| 2012 FY | - JPY | -25.38% |
| 2012 Q4 | -240.67 Million JPY | 13.05% |
| 2012 Q3 | -276.79 Million JPY | -15.07% |
| 2012 Q2 | -240.54 Million JPY | 20.31% |
| 2011 FY | - JPY | 3.65% |
| 2011 Q1 | -261.47 Million JPY | -11.2% |
| 2011 Q4 | -241.59 Million JPY | 13.46% |
| 2011 Q3 | -279.17 Million JPY | 4.05% |
| 2011 Q2 | -290.95 Million JPY | -11.28% |
| 2010 Q1 | -263.13 Million JPY | -339.49% |
| 2010 Q3 | -277.9 Million JPY | -14.55% |
| 2010 Q4 | -235.14 Million JPY | 15.39% |
| 2010 Q2 | -242.59 Million JPY | 7.81% |
| 2010 FY | - JPY | -1.34% |
| 2009 FY | - JPY | 3.3% |
| 2009 Q3 | -225.9 Million JPY | 2.95% |
| 2009 Q2 | -232.76 Million JPY | 15.21% |
| 2009 Q1 | -274.51 Million JPY | -404.93% |
| 2009 Q4 | -59.87 Million JPY | 73.5% |
| 2008 FY | - JPY | -14.5% |
| 2008 Q3 | -252.59 Million JPY | -0.37% |
| 2008 Q2 | -251.65 Million JPY | 3.77% |
| 2008 Q1 | -261.52 Million JPY | 0.0% |
| 2008 Q4 | -54.36 Million JPY | 78.48% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | 74.448% |
| PRISM BioLab Co.,LTD | -488.13 Million JPY | 150.153% |
| GNI Group Ltd. | 14.48 Billion JPY | 98.31% |
| Linical Co., Ltd. | 1.24 Billion JPY | 80.371% |
| Trans Genic Inc. | 240.95 Million JPY | -1.603% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | 118.056% |
| Soiken Holdings Inc. | -583.2 Million JPY | 141.977% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | 140.593% |
| AnGes, Inc. | -8.86 Billion JPY | 102.763% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 119.044% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 103.309% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | -91.101% |
| NanoCarrier Co., Ltd. | -863 Million JPY | 128.368% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | 122.423% |
| CanBas Co., Ltd. | 53.65 Million JPY | -356.308% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | 131.565% |
| RaQualia Pharma Inc. | -111.8 Million JPY | 318.973% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | 120.204% |
| Kidswell Bio Corporation | -1.38 Billion JPY | 117.73% |
| PeptiDream Inc. | 7.37 Billion JPY | 96.681% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 112.687% |
| Ribomic Inc. | -1.01 Billion JPY | 124.179% |
| SanBio Company Limited | -4.52 Billion JPY | 105.41% |
| Healios K.K. | -3 Billion JPY | 108.141% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 121.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 117.574% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 117.462% |
| StemRIM | -2.03 Billion JPY | 112.048% |
| CellSource Co., Ltd. | 1.3 Billion JPY | 81.261% |
| FunPep Company Limited | -952 Million JPY | 125.716% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 127.546% |
| Stella Pharma Corporation | -723.85 Million JPY | 133.821% |
| TMS Co., Ltd. | -937 Million JPY | 126.127% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 131.573% |
| Cuorips Inc. | -518 Million JPY | 147.261% |
| K Pharma,Inc. | 366.05 Million JPY | 33.122% |
| Takara Bio Inc. | 8.02 Billion JPY | 96.949% |
| ReproCELL Incorporated | 8.24 Million JPY | -2869.242% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | -178.394% |
| StemCell Institute Inc. | 534.35 Million JPY | 54.185% |
| CellSeed Inc. | -836.51 Million JPY | 129.266% |